Alpha-gal syndrome
MONDO:0100001An IgE antibody response to a mammalian oligosaccharide epitope, galactose-alpha-1,3-galactose (alpha-gal).
Also known as: AGS, allergic galactose-alpha-1,3-galactose disease, alpha-gal allergy, red meat allergy, tick bite meat allergy
18 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Massive asthma study tests phone apps and simple home fixes
Disease control Not yet recruitingThis large study aims to create a digital screening and management system for adults with asthma and allergies. Nearly 10,000 participants will use a smartphone platform to track symptoms and receive guidance on three non-drug strategies: avoiding allergens (like dust mites), inc…
Phase: NA • Sponsor: Beijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Modified pork could revolutionize Alpha-Gal allergy testing
Diagnosis Not yet recruitingThis study tests whether specially modified pork (alpha-gal knockout) causes fewer allergic reactions than regular pork in people with alpha-gal syndrome. Each of the 160 participants will eat both types of pork on different days to see which one is safer for diagnosis. The goal …
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
New hope for Tick-Bite survivors: mast cell drugs aim to ease lingering symptoms
Symptom relief Not yet recruitingThis study tests whether medications that calm mast cells (ketotifen and cromolyn) can safely reduce persistent symptoms like fatigue, pain, and brain fog in people who had a tick-borne illness. Fifty adults aged 21-65 will receive either one of these drugs or a standard antihist…
Phase: PHASE2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New allergy shot for teens enters early safety testing
Symptom relief Not yet recruitingThis early-stage study tests a new injection called JYB1904 in 12 teenagers aged 12-17 with allergies like hay fever, asthma, or food allergies. The main goal is to see if the drug is safe and how the body processes it. Participants will be closely monitored for side effects and …
Phase: PHASE1 • Sponsor: Jemincare • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC